SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Stock Price Down 0.2% – Time to Sell?

Posted by Stephan Jacobs on Dec 20th, 2025

Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) traded down 0.2% during trading on Thursday . The company traded as low as $54.95 and last traded at $55.26. 38,938 shares changed hands during mid-day trading, a decline of 25% from the average session volume of 51,751 shares. The stock had previously closed at $55.35.

SPDR S&P Pharmaceuticals ETF Stock Performance

The firm has a market capitalization of $207.98 million, a PE ratio of 14.28 and a beta of 0.60. The stock’s 50-day simple moving average is $51.72 and its 200-day simple moving average is $46.88.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

A number of institutional investors have recently bought and sold shares of XPH. Advisory Services Network LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth approximately $34,000. Clark Capital Management Group Inc. bought a new stake in SPDR S&P Pharmaceuticals ETF in the third quarter worth $2,248,000. Raymond James Financial Inc. boosted its holdings in SPDR S&P Pharmaceuticals ETF by 26.3% in the third quarter. Raymond James Financial Inc. now owns 16,333 shares of the company’s stock worth $783,000 after acquiring an additional 3,405 shares in the last quarter. UBS Group AG grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 16.0% in the third quarter. UBS Group AG now owns 36,013 shares of the company’s stock worth $1,726,000 after acquiring an additional 4,965 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of SPDR S&P Pharmaceuticals ETF by 2.5% during the third quarter. JPMorgan Chase & Co. now owns 58,699 shares of the company’s stock valued at $2,814,000 after acquiring an additional 1,441 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Company Profile

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.